TNF and MAP kinase signalling pathways

Wong, 2008, TNFalpha blockade in human diseases: mechanisms and future directions, Clin Immunol, 126, 121, 10.1016/j.clim.2007.08.013 Janes, 2006, The response of human epithelial cells to TNF involves an inducible autocrine cascade, Cell, 124, 1225, 10.1016/j.cell.2006.01.041 Nebreda, 2000, p38 MAP kinases: beyond the stress response, Trends Biochem Sci, 25, 257, 10.1016/S0968-0004(00)01595-4 Schieven, 2005, The biology of p38 kinase: a central role in inflammation, Curr Top Med Chem, 5, 921, 10.2174/1568026054985902 Manning, 2003, Targeting JNK for therapeutic benefit: from junk to gold?, Nat Rev Drug Discov, 2, 554, 10.1038/nrd1132 Kyriakis, 2012, Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update, Physiol Rev, 92, 689, 10.1152/physrev.00028.2011 Morrison, 2003, Regulation of MAP kinase signaling modules by scaffold proteins in mammals, Annu Rev Cell Dev Biol, 19, 91, 10.1146/annurev.cellbio.19.111401.091942 Enslen, 2001, Regulation of MAP kinases by docking domains, Biol Cell, 93, 5, 10.1016/S0248-4900(01)01156-X Das, 2005, Tpl2/cot signals activate ERK, JNK, and NF-kappaB in a cell-type and stimulus-specific manner, J Biol Chem, 280, 23748, 10.1074/jbc.M412837200 Gantke, 2012, IkappaB kinase regulation of the TPL-2/ERK MAPK pathway, Immunol Rev, 246, 168, 10.1111/j.1600-065X.2012.01104.x Arthur, 2013, Mitogen-activated protein kinases in innate immunity, Nat Rev Immunol, 13, 679, 10.1038/nri3495 Chen, 2012, Ubiquitination in signaling to and activation of IKK, Immunol Rev, 246, 95, 10.1111/j.1600-065X.2012.01108.x Yang, 2012, Coordinate regulation of TPL-2 and NF-kappaB signaling in macrophages by NF-kappaB1 p105, Mol Cell Biol, 32, 3438, 10.1128/MCB.00564-12 Beinke, 2004, Lipopolysaccharide activation of the TPL-2/MEK/extracellular signal-regulated kinase mitogen-activated protein kinase cascade is regulated by IkappaB kinase-induced proteolysis of NF-kappaB1 p105, Mol Cell Biol, 24, 9658, 10.1128/MCB.24.21.9658-9667.2004 Roget, 2012, IkappaB kinase 2 regulates TPL-2 activation of extracellular signal-regulated kinases 1 and 2 by direct phosphorylation of TPL-2 serine 400, Mol Cell Biol, 32, 4684, 10.1128/MCB.01065-12 Robinson, 2007, Phosphorylation of TPL-2 on serine 400 is essential for lipopolysaccharide activation of extracellular signal-regulated kinase in macrophages, Mol Cell Biol, 27, 7355, 10.1128/MCB.00301-07 Ajibade, 2013, Cell type-specific function of TAK1 in innate immune signaling, Trends Immunol, 34, 307, 10.1016/j.it.2013.03.007 Ori, 2013, Essential roles of K63-linked polyubiquitin-binding proteins TAB2 and TAB3 in B cell activation via MAPKs, J Immunol, 190, 4037, 10.4049/jimmunol.1300173 Davis, 2000, Signal transduction by the JNK group of MAP kinases, Cell, 103, 239, 10.1016/S0092-8674(00)00116-1 Cuadrado, 2010, Mechanisms and functions of p38 MAPK signalling, Biochem J, 429, 403, 10.1042/BJ20100323 Tournier, 2001, MKK7 is an essential component of the JNK signal transduction pathway activated by proinflammatory cytokines, Genes Dev, 15, 1419, 10.1101/gad.888501 Fleming, 2000, Synergistic activation of stress-activated protein kinase 1/c-Jun N-terminal kinase (SAPK1/JNK) isoforms by mitogen-activated protein kinase kinase 4 (MKK4) and MKK7, Biochem J, 352, 145, 10.1042/0264-6021:3520145 Ventura, 2004, JNK potentiates TNF-stimulated necrosis by increasing the production of cytotoxic reactive oxygen species, Genes Dev, 18, 2905, 10.1101/gad.1223004 Brancho, 2003, Mechanism of p38 MAP kinase activation in vivo, Genes Dev, 17, 1969, 10.1101/gad.1107303 Remy, 2010, Differential activation of p38MAPK isoforms by MKK6 and MKK3, Cell Signal, 22, 660, 10.1016/j.cellsig.2009.11.020 Tobiume, 2001, ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis, EMBO Rep, 2, 222, 10.1093/embo-reports/kve046 Yazdanpanah, 2009, Riboflavin kinase couples TNF receptor 1 to NADPH oxidase, Nature, 460, 1159, 10.1038/nature08206 Saitoh, 1998, Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1, EMBO J, 17, 2596, 10.1093/emboj/17.9.2596 Nishitoh, 1998, ASK1 is essential for JNK/SAPK activation by TRAF2, Mol Cell, 2, 389, 10.1016/S1097-2765(00)80283-X Noguchi, 2005, Recruitment of tumor necrosis factor receptor-associated factor family proteins to apoptosis signal-regulating kinase 1 signalosome is essential for oxidative stress-induced cell death, J Biol Chem, 280, 37033, 10.1074/jbc.M506771200 Fujino, 2007, Thioredoxin and TRAF family proteins regulate reactive oxygen species-dependent activation of ASK1 through reciprocal modulation of the N-terminal homophilic interaction of ASK1, Mol Cell Biol, 27, 8152, 10.1128/MCB.00227-07 Liu, 2000, Activation of apoptosis signal-regulating kinase 1 (ASK1) by tumor necrosis factor receptor-associated factor 2 requires prior dissociation of the ASK1 inhibitor thioredoxin, Mol Cell Biol, 20, 2198, 10.1128/MCB.20.6.2198-2208.2000 Iriyama, 2009, ASK1 and ASK2 differentially regulate the counteracting roles of apoptosis and inflammation in tumorigenesis, EMBO J, 28, 843, 10.1038/emboj.2009.32 Takeda, 2007, Apoptosis signal-regulating kinase (ASK) 2 functions as a mitogen-activated protein kinase kinase kinase in a heteromeric complex with ASK1, J Biol Chem, 282, 7522, 10.1074/jbc.M607177200 Schlesinger, 1998, The TAO of MEKK, Front Biosci, 3, D1181, 10.2741/A354 Xia, 2000, MEK kinase 1 is critically required for c-Jun N-terminal kinase activation by proinflammatory stimuli and growth factor-induced cell migration, PNAS, 97, 5243, 10.1073/pnas.97.10.5243 Yujiri, 2000, MEK kinase 1 gene disruption alters cell migration and c-Jun NH2-terminal kinase regulation but does not cause a measurable defect in NF-kappa B activation, PNAS, 97, 7272, 10.1073/pnas.130176697 Gallagher, 2007, Kinase MEKK1 is required for CD40-dependent activation of the kinases Jnk and p38, germinal center formation, B cell proliferation and antibody production, Nat Immunol, 8, 57, 10.1038/ni1421 Yamazaki, 2009, Two mechanistically and temporally distinct NF-kappaB activation pathways in IL-1 signaling, Sci Signal, 2, ra66, 10.1126/scisignal.2000387 Chen, 2013, Regulation of NF-kappaB by ubiquitination, Curr Opin Immunol, 25, 4, 10.1016/j.coi.2012.12.005 Sakurai, 2012, Targeting of TAK1 in inflammatory disorders and cancer, Trends Pharmacol Sci, 33, 522, 10.1016/j.tips.2012.06.007 Kant, 2011, TNF-stimulated MAP kinase activation mediated by a Rho family GTPase signaling pathway, Genes Dev, 25, 2069, 10.1101/gad.17224711 Ajibade, 2012, TAK1 negatively regulates NF-kappaB and p38 MAP kinase activation in Gr-1+CD11b+ neutrophils, Immunity, 36, 43, 10.1016/j.immuni.2011.12.010 Eftychi, 2012, Myeloid TAK1 acts as a negative regulator of the LPS response and mediates resistance to endotoxemia, PLoS One, 7, e31550, 10.1371/journal.pone.0031550 Wojciak-Stothard, 1998, Regulation of TNF-alpha-induced reorganization of the actin cytoskeleton and cell–cell junctions by Rho, Rac, and Cdc42 in human endothelial cells, J Cell Physiol, 176, 150, 10.1002/(SICI)1097-4652(199807)176:1<150::AID-JCP17>3.0.CO;2-B Kim, 1999, Roles of phosphatidylinositol 3-kinase and Rac in the nuclear signaling by tumor necrosis factor-alpha in rat-2 fibroblasts, J Biol Chem, 274, 24372, 10.1074/jbc.274.34.24372 Puls, 1999, Activation of the small GTPase Cdc42 by the inflammatory cytokines TNF(alpha) and IL-1, and by the Epstein–Barr virus transforming protein LMP1, J Cell Sci, 112, 2983, 10.1242/jcs.112.17.2983 Hanna, 2001, Tumor necrosis factor-alpha induces stress fiber formation through ceramide production: role of sphingosine kinase, Mol Biol Cell, 12, 3618, 10.1091/mbc.12.11.3618 Kakiashvili, 2009, GEF-H1 mediates tumor necrosis factor-alpha-induced Rho activation and myosin phosphorylation: role in the regulation of tubular paracellular permeability, J Biol Chem, 284, 11454, 10.1074/jbc.M805933200 Kim, 2007, TNF-induced activation of the Nox1 NADPH oxidase and its role in the induction of necrotic cell death, Mol Cell, 26, 675, 10.1016/j.molcel.2007.04.021 Peng, 2011, Protein kinase C-alpha signals P115RhoGEF phosphorylation and RhoA activation in TNF-alpha-induced mouse brain microvascular endothelial cell barrier dysfunction, J Neuroinflammation, 8, 28, 10.1186/1742-2094-8-28 Coso, 1995, The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway, Cell, 81, 1137, 10.1016/S0092-8674(05)80018-2 Minden, 1995, Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs, Cell, 81, 1147, 10.1016/S0092-8674(05)80019-4 Teramoto, 1996, Signaling from the small GTP-binding proteins Rac1 and Cdc42 to the c-Jun N-terminal kinase/stress-activated protein kinase pathway. A role for mixed lineage kinase 3/protein-tyrosine kinase 1, a novel member of the mixed lineage kinase family, J Biol Chem, 271, 27225, 10.1074/jbc.271.44.27225 Gallo, 2002, Mixed-lineage kinase control of JNK and p38 MAPK pathways, Nat Rev Mol Cell Biol, 3, 663, 10.1038/nrm906 Humphrey, 2013, Lysine 63-linked ubiquitination modulates mixed lineage kinase-3 interaction with JIP1 scaffold protein in cytokine-induced pancreatic beta cell death, J Biol Chem, 288, 2428, 10.1074/jbc.M112.425884 Korchnak, 2009, Cytokine-induced activation of mixed lineage kinase 3 requires TRAF2 and TRAF6, Cell Signal, 21, 1620, 10.1016/j.cellsig.2009.06.008 Sondarva, 2010, TRAF2-MLK3 interaction is essential for TNF-alpha-induced MLK3 activation, Cell Res, 20, 89, 10.1038/cr.2009.125 Gaestel, 2009, Targeting innate immunity protein kinase signalling in inflammation, Nat Rev Drug Discov, 8, 480, 10.1038/nrd2829 Utsumi, 1995, Human pro-tumor necrosis factor: molecular determinants of membrane translocation, sorting, and maturation, Mol Cell Biol, 15, 6398, 10.1128/MCB.15.11.6398 Kriegler, 1988, A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF, Cell, 53, 45, 10.1016/0092-8674(88)90486-2 Moss, 1997, Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha, Nature, 385, 733, 10.1038/385733a0 O’Malley, 1988, Journal of the National Cancer Institute, Vol. 29, 1962: action of bacterial polysaccharide on tumors. II. Damage of sarcoma 37 by serum of mice treated with Serratia marcescens polysaccharide, and induced tolerance, Nutr Rev, 46, 389, 10.1111/j.1753-4887.1988.tb05376.x Gonzalez-Teran, 2013, Eukaryotic elongation factor 2 controls TNF-alpha translation in LPS-induced hepatitis, J Clin Invest, 123, 164, 10.1172/JCI65124 Trotta, 1996, Fc gamma R-dependent mitogen-activated protein kinase activation in leukocytes: a common signal transduction event necessary for expression of TNF-alpha and early activation genes, J Exp Med, 184, 1027, 10.1084/jem.184.3.1027 Rutault, 2001, Combinations of ERK and p38 MAPK inhibitors ablate tumor necrosis factor-alpha (TNF-alpha) mRNA induction. Evidence for selective destabilization of TNF-alpha transcripts, J Biol Chem, 276, 6666, 10.1074/jbc.M005486200 Hoffmeyer, 1999, Different mitogen-activated protein kinase signaling pathways cooperate to regulate tumor necrosis factor alpha gene expression in T lymphocytes, J Biol Chem, 274, 4319, 10.1074/jbc.274.7.4319 Deleault, 2008, Tristetraprolin regulates TNF TNF-alpha mRNA stability via a proteasome dependent mechanism involving the combined action of the ERK and p38 pathways, Mol Immunol, 45, 13, 10.1016/j.molimm.2007.05.017 Yao, 1997, Lipopolysaccharide induction of the tumor necrosis factor-alpha promoter in human monocytic cells. Regulation by Egr-1, c-Jun, and NF-kappaB transcription factors, J Biol Chem, 272, 17795, 10.1074/jbc.272.28.17795 Tsai, 2000, A lipopolysaccharide-specific enhancer complex involving Ets, Elk-1, Sp1, and CREB binding protein and p300 is recruited to the tumor necrosis factor alpha promoter in vivo, Mol Cell Biol, 20, 6084, 10.1128/MCB.20.16.6084-6094.2000 Kishore, 2004, Lipopolysaccharide-mediated signal transduction: stabilization of TNF-alpha mRNA contributes to increased lipopolysaccharide-stimulated TNF-alpha production by Kupffer cells after chronic ethanol feeding, Comp Hepatol, 3, S31, 10.1186/1476-5926-2-S1-S31 Kaminska, 2005, MAPK signalling pathways as molecular targets for anti-inflammatory therapy—from molecular mechanisms to therapeutic benefits, Biochim Biophys Acta, 1754, 253, 10.1016/j.bbapap.2005.08.017 Zhu, 2000, Regulation of TNF expression by multiple mitogen-activated protein kinase pathways, J Immunol, 164, 6349, 10.4049/jimmunol.164.12.6349 Means, 2000, Activation of TNF-alpha transcription utilizes distinct MAP kinase pathways in different macrophage populations, J Leukoc Biol, 67, 885, 10.1002/jlb.67.6.885 Dyson, 2005, MAP kinase-mediated phosphorylation of distinct pools of histone H3 at S10 or S28 via mitogen- and stress-activated kinase 1/2, J Cell Sci, 118, 2247, 10.1242/jcs.02373 Wiggin, 2002, MSK1 and MSK2 are required for the mitogen- and stress-induced phosphorylation of CREB and ATF1 in fibroblasts, Mol Cell Biol, 22, 2871, 10.1128/MCB.22.8.2871-2881.2002 Dumitru, 2000, TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway, Cell, 103, 1071, 10.1016/S0092-8674(00)00210-5 Skinner, 2008, Extracellular signal-regulated kinase regulation of tumor necrosis factor-alpha mRNA nucleocytoplasmic transport requires TAP-NxT1 binding and the AU-rich element, J Biol Chem, 283, 3191, 10.1074/jbc.M705575200 George, 2009, Cot/Tpl-2 protein kinase as a target for the treatment of inflammatory disease, Curr Top Med Chem, 9, 611, 10.2174/156802609789007345 Fukunaga, 1997, MNK1, a new MAP kinase-activated protein kinase, isolated by a novel expression screening method for identifying protein kinase substrates, EMBO J, 16, 1921, 10.1093/emboj/16.8.1921 Waskiewicz, 1997, Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2, EMBO J, 16, 1909, 10.1093/emboj/16.8.1909 Mahalingam, 2001, Phosphorylation of mammalian eIF4E by Mnk1 and Mnk2: tantalizing prospects for a role in translation, Prog Mol Subcell Biol, 27, 132 Buxade, 2005, The Mnks are novel components in the control of TNF alpha biosynthesis and phosphorylate and regulate hnRNP A1, Immunity, 23, 177, 10.1016/j.immuni.2005.06.009 Rousseau, 2008, TPL2-mediated activation of ERK1 and ERK2 regulates the processing of pre-TNF alpha in LPS-stimulated macrophages, J Cell Sci, 121, 149, 10.1242/jcs.018671 Moss, 1997, Structural features and biochemical properties of TNF-alpha converting enzyme (TACE), J Neuroimmunol, 72, 127, 10.1016/S0165-5728(96)00180-4 Ventura, 2003, c-Jun NH(2)-terminal kinase is essential for the regulation of AP-1 by tumor necrosis factor, Mol Cell Biol, 23, 2871, 10.1128/MCB.23.8.2871-2882.2003 Das, 2009, Induction of hepatitis by JNK-mediated expression of TNF-alpha, Cell, 136, 249, 10.1016/j.cell.2008.11.017 Han, 2013, JNK expression by macrophages promotes obesity-induced insulin resistance and inflammation, Science, 339, 218, 10.1126/science.1227568 Lee, 1994, A protein kinase involved in the regulation of inflammatory cytokine biosynthesis, Nature, 372, 739, 10.1038/372739a0 Beardmore, 2005, Generation and characterization of p38beta (MAPK11) gene-targeted mice, Mol Cell Biol, 25, 10454, 10.1128/MCB.25.23.10454-10464.2005 Ittner, 2012, Regulation of PTEN activity by p38delta-PKD1 signaling in neutrophils confers inflammatory responses in the lung, J Exp Med, 209, 2229, 10.1084/jem.20120677 Sumara, 2009, Regulation of PKD by the MAPK p38delta in insulin secretion and glucose homeostasis, Cell, 136, 235, 10.1016/j.cell.2008.11.018 Cuenda, 2007, p38 MAP-kinases pathway regulation, function and role in human diseases, Biochim Biophys Acta, 1773, 1358, 10.1016/j.bbamcr.2007.03.010 Risco, 2012, New Insights into the p38gamma and p38delta MAPK Pathways, J Signal Transduct, 2012, 520289, 10.1155/2012/520289 Kuma, 2005, BIRB796 inhibits all p38 MAPK isoforms in vitro and in vivo, J Biol Chem, 280, 19472, 10.1074/jbc.M414221200 Sabio, 2005, p38gamma regulates the localisation of SAP97 in the cytoskeleton by modulating its interaction with GKAP, EMBO J, 24, 1134, 10.1038/sj.emboj.7600578 Kang, 2008, Macrophage deletion of p38alpha partially impairs lipopolysaccharide-induced cellular activation, J Immunol, 180, 5075, 10.4049/jimmunol.180.7.5075 O’Keefe, 2007, Chemical genetics define the roles of p38alpha and p38beta in acute and chronic inflammation, J Biol Chem, 282, 34663, 10.1074/jbc.M704236200 Campbell, 2004, A novel mechanism for TNF-alpha regulation by p38 MAPK: involvement of NF-kappa B with implications for therapy in rheumatoid arthritis, J Immunol, 173, 6928, 10.4049/jimmunol.173.11.6928 Wang, 1996, Stress-induced phosphorylation and activation of the transcription factor CHOP (GADD153) by p38 MAP Kinase, Science, 272, 1347, 10.1126/science.272.5266.1347 Han, 1997, Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation, Nature, 386, 296, 10.1038/386296a0 Raingeaud, 1996, MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway, Mol Cell Biol, 16, 1247, 10.1128/MCB.16.3.1247 Carter, 1999, The p38 mitogen-activated protein kinase is required for NF-kappaB-dependent gene expression. The role of TATA-binding protein (TBP), J Biol Chem, 274, 30858, 10.1074/jbc.274.43.30858 Saccani, 2002, p38-Dependent marking of inflammatory genes for increased NF-kappa B recruitment, Nat Immunol, 3, 69, 10.1038/ni748 Vermeulen, 2003, Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1), EMBO J, 22, 1313, 10.1093/emboj/cdg139 Bowie, 2000, Vitamin C inhibits NF-kappa B activation by TNF via the activation of p38 mitogen-activated protein kinase, J Immunol, 165, 7180, 10.4049/jimmunol.165.12.7180 Alpert, 1999, Cell stress and MKK6b-mediated p38 MAP kinase activation inhibit tumor necrosis factor-induced IkappaB phosphorylation and NF-kappaB activation, J Biol Chem, 274, 22176, 10.1074/jbc.274.32.22176 Cheung, 2003, Feedback control of the protein kinase TAK1 by SAPK2a/p38alpha, EMBO J, 22, 5793, 10.1093/emboj/cdg552 Kotlyarov, 1999, MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis, Nat Cell Biol, 1, 94, 10.1038/10061 Caput, 1986, Identification of a common nucleotide sequence in the 3′-untranslated region of mRNA molecules specifying inflammatory mediators, PNAS, 83, 1670, 10.1073/pnas.83.6.1670 Grzybowska, 2001, Regulatory functions of 3′UTRs, Biochem Biophys Res Commun, 288, 291, 10.1006/bbrc.2001.5738 Neininger, 2002, MK2 targets AU-rich elements and regulates biosynthesis of tumor necrosis factor and interleukin-6 independently at different post-transcriptional levels, J Biol Chem, 277, 3065, 10.1074/jbc.C100685200 Kontoyiannis, 1999, Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies, Immunity, 10, 387, 10.1016/S1074-7613(00)80038-2 Zaru, 2007, The MAPK-activated kinase Rsk controls an acute Toll-like receptor signaling response in dendritic cells and is activated through two distinct pathways, Nat Immunol, 8, 1227, 10.1038/ni1517 Chrestensen, 2004, MAPKAP kinase 2 phosphorylates tristetraprolin on in vivo sites including Ser178, a site required for 14-3-3 binding, J Biol Chem, 279, 10176, 10.1074/jbc.M310486200 Bollig, 2003, Affinity purification of ARE-binding proteins identifies polyA-binding protein 1 as a potential substrate in MK2-induced mRNA stabilization, Biochem Biophys Res Commun, 301, 665, 10.1016/S0006-291X(03)00015-9 Stoecklin, 2004, MK2-induced tristetraprolin:14-3-3 complexes prevent stress granule association and ARE-mRNA decay, EMBO J, 23, 1313, 10.1038/sj.emboj.7600163 Taylor, 1996, A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency, Immunity, 4, 445, 10.1016/S1074-7613(00)80411-2 Carballo, 1998, Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin, Science, 281, 1001, 10.1126/science.281.5379.1001 Qiu, 2012, Myeloid-specific tristetraprolin deficiency in mice results in extreme lipopolysaccharide sensitivity in an otherwise minimal phenotype, J Immunol, 188, 5150, 10.4049/jimmunol.1103700 Hitti, 2006, Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element, Mol Cell Biol, 26, 2399, 10.1128/MCB.26.6.2399-2407.2006 Mahtani, 2001, Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability, Mol Cell Biol, 21, 6461, 10.1128/MCB.21.9.6461-6469.2001 Clement, 2011, Phosphorylation of tristetraprolin by MK2 impairs AU-rich element mRNA decay by preventing deadenylase recruitment, Mol Cell Biol, 31, 256, 10.1128/MCB.00717-10 Marchese, 2010, MAPKAP kinase 2 blocks tristetraprolin-directed mRNA decay by inhibiting CAF1 deadenylase recruitment, J Biol Chem, 285, 27590, 10.1074/jbc.M110.136473 Tiedje, 2012, The p38/MK2-driven exchange between tristetraprolin and HuR regulates AU-rich element-dependent translation, PLoS Genet, 8, e1002977, 10.1371/journal.pgen.1002977 Risco, 2012, p38gamma and p38delta kinases regulate the Toll-like receptor 4 (TLR4)-induced cytokine production by controlling ERK1/2 protein kinase pathway activation, PNAS, 109, 11200, 10.1073/pnas.1207290109